Pfizer “isn’t sure” its vaccine will stop Covid-19 transmission



[ad_1]

Health

Short URL

https://cdnfr1.img.sputniknews.com/img/07e4/0b/12/1044789885_0:0:3303:1859_1200x675_80_0_0_cad8465d10f3bb59ade5586c12765c15.jpg

Sputnik France

https://cdnfr2.img.sputniknews.com/i/logo.png

https://fr.sputniknews.com/sante/202012041044874708-pfizer-nest-pas-certain-que-son-vaccin-stoppe-la-transmission-du-covid-19/

“This is an aspect that needs to be examined”: according to the CEO of the pharmaceutical giant Pfizer, Albert Bourla, the company still does not know if those who receive its vaccine against Covid-19 can still transmit the virus.

As the UK became the first country to authorize Pfizer’s vaccine, its CEO Albert Bourla gave an interview to NBC News giving details about the vaccine.

“Even though I have received this protection, I am still able to do it [le coronavirus, ndlr] pass it on to other people? Asked NBC reporter Lester Holt.

“I think it’s something that needs to be looked into,” the CEO replied. “We’re not sure yet what we know.”

Criticism of pharmaceutical nationalism

The UK is the first country in the world to authorize Pfizer’s vaccine, of which 40 million doses have been purchased. It will be available from “next week,” a British government spokesman said Wednesday (2 December).

The UK government later said Brexit made the UK the first Western country to allow a vaccine. A claim that drew criticism of pharmaceutical nationalism.

95% efficiency

On November 18, American pharmaceutical giant Pfizer and its German partner BioNTech announced that their Covid-19 vaccine candidate was 95% effective.

A dose of Pfizer’s vaccine will cost $ 19.50 (about $ 16), so the vaccination price per person will be about $ 40 (almost $ 33).

.

[ad_2]
Source link